Nisha Almeida is manager of the Health Technology Assessment Unit (TAU) of the MUHC. She holds a BSc in Molecular Biology and a PhD in Epidemiology and Biostatistics from McGill University. She has advanced training in epidemiological and biostatistical methods and specific experience in the evaluation and implementation of health technologies and interventions.
She was previously a senior epidemiologist at TAU, and led the implementation of hospital quality improvement initiatives while coordinating the participation of various stakeholders, data collection and analytical efforts. She played a key role in the development of a decision-aid tool to translate scientific evidence into hospital policy recommendations. Her work has been published in the peer-reviewed literature and she has been successful in securing funds for hospital initiatives. Nisha is particularly interested in harnessing hospital data to improve health outcomes and services.
Marie Belmonte joined the Technology Assessment Unit on October 1, 2018. She is an administrative technician with the Technology Assessment Unit at the McGill University Health Centre. She holds a Bachelor of Commerce degree in marketing from Concordia University. She has strong organizational and analytical skills.
James Brophy is the Chair of the Policy Committee of the Technology Assessment Unit of the McGill University Health Centre. He is a practicing cardiologist with a Ph.D. in Epidemiology and Biostatistics. He is a funded scholar from the Fonds de Recherche du Quebec (Santé) with a chair in health technology assessment and evidence-based medicine. His research interests center on cardiovascular epidemiology with a special interest in pharmacoepidemiology, outcomes research, medical decision making as well as health technology assessments, including economic analyses. He has published over 150 peer-reviewed articles. He is a full professor in the departments of medicine and epidemiology and biostatistics at McGill University.
Thiphavone Oudanonh is a Research Assistant at the Technology Assessment Unit of the McGill University Health Centre. She holds a BSc in Biochemistry and a Certificate in Quantitative Methods from UQAM as well as an MSc in Epidemiology from Laval University. Her main goal is to provide valid evidence to support health-related decisions.
Alain Lapointe is a visiting consultant at the MUHC's Technology Evaluation Unit. He joined the CHUM/MUHC Technology Assessment Unit in November 2006 and was an affiliated member until his retirement. He holds a master's degree in mechanical engineering from École Polytechnique de Montréal, a master's degree in health administration from the University de Montréal, a medical faculty and a doctorate in applied sciences (biomedical engineering) at the École Polytechnique de Montréal. He completed his postdoctoral studies at Hôpital Sacré-Coeur and joined the research team (a division of cardiology) at the Hôtel-Dieu Hospital (CHUM). In 1981, Alain founded the biomedical engineering department of the Hôtel-Dieu Hospital. After completing his master's degree in health administration in 1996, he served as president of the Association of Biomedical Physicians and Engineers of Quebec for a period of four years. In 1997, he led the new physical and biomedical engineering group at the CHUM (University of Montreal Hospital Centre). In 2001, he became Director of Health Technology Planning at the CHUM Implementation Corporation (SICHUM) and in October 2002, Alain joined the management team of the Technology Resources Group (CHUM). He was a director of the Office of Project Management.